| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas aeruginosa | 63 | 2023 | 1219 | 10.580 |
Why?
|
| Pseudomonas Infections | 31 | 2023 | 613 | 6.580 |
Why?
|
| Quorum Sensing | 20 | 2023 | 131 | 6.290 |
Why?
|
| Burns | 25 | 2023 | 1815 | 2.720 |
Why?
|
| Gene Expression Regulation, Bacterial | 13 | 2023 | 1122 | 2.060 |
Why?
|
| Acetophenones | 5 | 2016 | 48 | 2.020 |
Why?
|
| Virulence | 33 | 2022 | 1333 | 1.890 |
Why?
|
| Bacterial Proteins | 22 | 2023 | 3854 | 1.650 |
Why?
|
| Anti-Bacterial Agents | 17 | 2022 | 7182 | 1.510 |
Why?
|
| Arabidopsis | 12 | 2014 | 459 | 1.410 |
Why?
|
| Biofilms | 5 | 2022 | 617 | 1.410 |
Why?
|
| Histone Deacetylase 1 | 2 | 2023 | 137 | 1.390 |
Why?
|
| Virulence Factors | 10 | 2023 | 509 | 1.240 |
Why?
|
| Plant Diseases | 9 | 2014 | 150 | 1.190 |
Why?
|
| Muscle, Skeletal | 17 | 2019 | 4925 | 1.040 |
Why?
|
| Regulon | 3 | 2017 | 69 | 0.980 |
Why?
|
| Drosophila melanogaster | 14 | 2020 | 1708 | 0.950 |
Why?
|
| Smoke Inhalation Injury | 2 | 2019 | 49 | 0.820 |
Why?
|
| Sepsis | 4 | 2023 | 2593 | 0.740 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2021 | 249 | 0.740 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2019 | 1035 | 0.660 |
Why?
|
| Trauma Severity Indices | 2 | 2020 | 481 | 0.660 |
Why?
|
| Cross Infection | 2 | 2020 | 1417 | 0.640 |
Why?
|
| Host-Pathogen Interactions | 4 | 2016 | 1480 | 0.640 |
Why?
|
| Bacterial Infections | 3 | 2019 | 1401 | 0.600 |
Why?
|
| Quinolones | 5 | 2016 | 367 | 0.600 |
Why?
|
| Multiple Organ Failure | 1 | 2019 | 389 | 0.580 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2021 | 1877 | 0.570 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 1182 | 0.530 |
Why?
|
| Electron Transport | 2 | 2016 | 211 | 0.530 |
Why?
|
| Microbial Viability | 2 | 2014 | 234 | 0.500 |
Why?
|
| Mice | 47 | 2023 | 81201 | 0.470 |
Why?
|
| Glutathione Transferase | 2 | 2014 | 595 | 0.450 |
Why?
|
| Magnetic Resonance Spectroscopy | 15 | 2018 | 3759 | 0.440 |
Why?
|
| Animals | 65 | 2023 | 168768 | 0.430 |
Why?
|
| Wound Infection | 2 | 2011 | 242 | 0.420 |
Why?
|
| Disease Models, Animal | 14 | 2020 | 18034 | 0.420 |
Why?
|
| Enzyme Inhibitors | 3 | 2018 | 3799 | 0.420 |
Why?
|
| Bacterial Load | 1 | 2012 | 153 | 0.420 |
Why?
|
| Wounds and Injuries | 5 | 2020 | 2400 | 0.410 |
Why?
|
| Quinolines | 5 | 2013 | 732 | 0.400 |
Why?
|
| Trans-Activators | 8 | 2011 | 2926 | 0.390 |
Why?
|
| Staphylococcus aureus | 2 | 2017 | 1453 | 0.390 |
Why?
|
| Bacteria | 3 | 2012 | 2115 | 0.390 |
Why?
|
| Plants | 5 | 2002 | 316 | 0.380 |
Why?
|
| Intestines | 2 | 2011 | 1924 | 0.380 |
Why?
|
| Biological Assay | 2 | 2014 | 652 | 0.380 |
Why?
|
| Drosophila Proteins | 7 | 2014 | 1703 | 0.370 |
Why?
|
| Mitochondrial Diseases | 1 | 2013 | 320 | 0.350 |
Why?
|
| Multigene Family | 2 | 2009 | 1102 | 0.340 |
Why?
|
| Genes, Bacterial | 6 | 2007 | 1079 | 0.340 |
Why?
|
| Genes, Regulator | 3 | 2007 | 378 | 0.330 |
Why?
|
| APACHE | 3 | 2020 | 277 | 0.330 |
Why?
|
| Pneumonia, Bacterial | 1 | 2011 | 316 | 0.320 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2019 | 567 | 0.310 |
Why?
|
| Epigenesis, Genetic | 2 | 2023 | 3646 | 0.310 |
Why?
|
| Bacteriophage lambda | 1 | 2008 | 147 | 0.310 |
Why?
|
| Recombinases | 1 | 2008 | 67 | 0.310 |
Why?
|
| Alkaline Phosphatase | 3 | 2020 | 867 | 0.300 |
Why?
|
| Signal Transduction | 15 | 2014 | 23404 | 0.300 |
Why?
|
| Mutagenesis | 6 | 2008 | 1264 | 0.290 |
Why?
|
| Methyltransferases | 1 | 2009 | 367 | 0.280 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 944 | 0.280 |
Why?
|
| Insulin Resistance | 4 | 2015 | 3864 | 0.280 |
Why?
|
| Drug Discovery | 1 | 2014 | 1058 | 0.280 |
Why?
|
| Colony Count, Microbial | 3 | 2017 | 331 | 0.270 |
Why?
|
| Immunity, Innate | 5 | 2012 | 2962 | 0.270 |
Why?
|
| Intestinal Diseases | 1 | 2011 | 530 | 0.270 |
Why?
|
| Pseudomonas | 3 | 2006 | 117 | 0.270 |
Why?
|
| Drug Tolerance | 2 | 2017 | 376 | 0.270 |
Why?
|
| Homoserine | 1 | 2005 | 12 | 0.260 |
Why?
|
| Adenosine Triphosphate | 7 | 2015 | 2027 | 0.260 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2015 | 17446 | 0.260 |
Why?
|
| Intestinal Mucosa | 4 | 2020 | 3037 | 0.260 |
Why?
|
| Injury Severity Score | 2 | 2020 | 1014 | 0.240 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 9 | 2010 | 3921 | 0.240 |
Why?
|
| Body Surface Area | 4 | 2019 | 199 | 0.240 |
Why?
|
| Cytokines | 2 | 2016 | 7323 | 0.240 |
Why?
|
| Transcription Factors | 12 | 2019 | 12207 | 0.230 |
Why?
|
| Homeostasis | 3 | 2020 | 3339 | 0.230 |
Why?
|
| Immunologic Factors | 1 | 2012 | 1580 | 0.220 |
Why?
|
| Area Under Curve | 2 | 2019 | 1655 | 0.220 |
Why?
|
| Models, Biological | 6 | 2014 | 9584 | 0.220 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2005 | 362 | 0.210 |
Why?
|
| Benzimidazoles | 2 | 2018 | 850 | 0.210 |
Why?
|
| Lactones | 1 | 2005 | 329 | 0.210 |
Why?
|
| Disease Susceptibility | 3 | 2020 | 1782 | 0.210 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2023 | 194 | 0.210 |
Why?
|
| Genetic Engineering | 1 | 2008 | 951 | 0.200 |
Why?
|
| Inflammation | 5 | 2023 | 10637 | 0.200 |
Why?
|
| Iron | 1 | 2010 | 1774 | 0.200 |
Why?
|
| Mitochondria | 9 | 2016 | 3514 | 0.200 |
Why?
|
| Hydroxyquinolines | 2 | 2016 | 19 | 0.200 |
Why?
|
| Mutation | 11 | 2014 | 29786 | 0.200 |
Why?
|
| Dendrimers | 1 | 2021 | 68 | 0.190 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2021 | 130 | 0.190 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2006 | 612 | 0.190 |
Why?
|
| Models, Statistical | 2 | 2015 | 5101 | 0.190 |
Why?
|
| Solvents | 1 | 2021 | 302 | 0.180 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2012 | 148 | 0.180 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2020 | 66 | 0.180 |
Why?
|
| Alginates | 2 | 2017 | 252 | 0.180 |
Why?
|
| Xanthine Oxidase | 1 | 2019 | 64 | 0.170 |
Why?
|
| ROC Curve | 2 | 2019 | 3528 | 0.170 |
Why?
|
| Ligands | 1 | 2006 | 3282 | 0.170 |
Why?
|
| Gene Expression | 3 | 2009 | 7798 | 0.170 |
Why?
|
| beta-Lactamases | 1 | 2021 | 306 | 0.170 |
Why?
|
| Culture Media | 3 | 2017 | 909 | 0.160 |
Why?
|
| NADP | 1 | 2019 | 226 | 0.160 |
Why?
|
| Antioxidants | 2 | 2019 | 1659 | 0.160 |
Why?
|
| Phospholipids | 1 | 2022 | 784 | 0.160 |
Why?
|
| Ion Channels | 3 | 2015 | 1056 | 0.160 |
Why?
|
| Plant Leaves | 4 | 2009 | 143 | 0.160 |
Why?
|
| Thienamycins | 1 | 2017 | 28 | 0.160 |
Why?
|
| Acetylcysteine | 1 | 2019 | 271 | 0.160 |
Why?
|
| Transcription, Genetic | 6 | 2017 | 7721 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 2 | 2006 | 5867 | 0.160 |
Why?
|
| Drug Resistance, Microbial | 1 | 2021 | 862 | 0.150 |
Why?
|
| Tobramycin | 1 | 2017 | 69 | 0.150 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2019 | 555 | 0.150 |
Why?
|
| Humans | 45 | 2023 | 744366 | 0.150 |
Why?
|
| 4-Quinolones | 1 | 2017 | 25 | 0.150 |
Why?
|
| Gene Expression Profiling | 10 | 2015 | 9445 | 0.150 |
Why?
|
| Volatile Organic Compounds | 1 | 2018 | 81 | 0.150 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 2865 | 0.150 |
Why?
|
| Mitochondrial Proteins | 3 | 2015 | 994 | 0.150 |
Why?
|
| Debridement | 1 | 2019 | 492 | 0.150 |
Why?
|
| Surface Plasmon Resonance | 1 | 2018 | 274 | 0.140 |
Why?
|
| Coenzyme A Ligases | 1 | 2016 | 43 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 21833 | 0.140 |
Why?
|
| Microbial Interactions | 1 | 2017 | 76 | 0.140 |
Why?
|
| Endotoxins | 1 | 2019 | 527 | 0.140 |
Why?
|
| DNA Primers | 4 | 2011 | 2891 | 0.140 |
Why?
|
| Base Sequence | 7 | 2011 | 12797 | 0.140 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 12244 | 0.140 |
Why?
|
| DNA, Bacterial | 4 | 2009 | 1465 | 0.140 |
Why?
|
| Fluid Therapy | 1 | 2019 | 593 | 0.130 |
Why?
|
| Citric Acid Cycle | 2 | 2013 | 232 | 0.130 |
Why?
|
| Burns, Inhalation | 1 | 2015 | 33 | 0.130 |
Why?
|
| ADP Ribose Transferases | 1 | 1995 | 90 | 0.130 |
Why?
|
| Protein Conformation | 2 | 2018 | 4010 | 0.130 |
Why?
|
| Autophagy | 1 | 2023 | 1297 | 0.130 |
Why?
|
| Resuscitation | 1 | 2019 | 658 | 0.130 |
Why?
|
| Mammals | 4 | 2014 | 1143 | 0.130 |
Why?
|
| Gastrointestinal Tract | 2 | 2012 | 814 | 0.120 |
Why?
|
| Male | 27 | 2021 | 350115 | 0.120 |
Why?
|
| Mitochondrial Membranes | 1 | 2016 | 174 | 0.120 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 2076 | 0.120 |
Why?
|
| Lactic Acid | 1 | 2019 | 1132 | 0.120 |
Why?
|
| Apoptosis | 6 | 2016 | 9724 | 0.120 |
Why?
|
| Skin Transplantation | 1 | 2019 | 1074 | 0.120 |
Why?
|
| Muscle Proteins | 1 | 2019 | 1158 | 0.120 |
Why?
|
| Tetrazolium Salts | 1 | 2013 | 96 | 0.120 |
Why?
|
| Logistic Models | 3 | 2019 | 13409 | 0.110 |
Why?
|
| Drug Resistance, Multiple | 1 | 2014 | 252 | 0.110 |
Why?
|
| Drug Synergism | 1 | 2017 | 1794 | 0.110 |
Why?
|
| Macrophages | 2 | 2023 | 5660 | 0.110 |
Why?
|
| Pyocyanine | 3 | 2008 | 18 | 0.110 |
Why?
|
| Thoracic Injuries | 1 | 2015 | 272 | 0.110 |
Why?
|
| Down-Regulation | 3 | 2011 | 3001 | 0.110 |
Why?
|
| Immune Evasion | 1 | 2016 | 360 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 2088 | 0.110 |
Why?
|
| Crystallography, X-Ray | 1 | 2018 | 2012 | 0.110 |
Why?
|
| Comorbidity | 2 | 2019 | 10388 | 0.110 |
Why?
|
| Cachexia | 2 | 2013 | 205 | 0.110 |
Why?
|
| Acinetobacter baumannii | 1 | 2013 | 107 | 0.110 |
Why?
|
| Lipid Metabolism | 5 | 2010 | 1889 | 0.110 |
Why?
|
| Hindlimb | 4 | 2008 | 504 | 0.110 |
Why?
|
| Enzyme Activation | 2 | 2009 | 3702 | 0.110 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2012 | 103 | 0.110 |
Why?
|
| DNA-Binding Proteins | 7 | 2006 | 9647 | 0.110 |
Why?
|
| Benzamides | 1 | 2017 | 1379 | 0.100 |
Why?
|
| Mitochondria, Muscle | 1 | 2013 | 171 | 0.100 |
Why?
|
| Contrast Media | 2 | 2018 | 5300 | 0.100 |
Why?
|
| Cefazolin | 1 | 2012 | 96 | 0.100 |
Why?
|
| Critical Illness | 2 | 2022 | 2670 | 0.100 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2012 | 452 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 894 | 0.100 |
Why?
|
| Sequence Deletion | 2 | 2008 | 1525 | 0.100 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 13991 | 0.100 |
Why?
|
| Thinness | 1 | 2015 | 480 | 0.100 |
Why?
|
| Transcription Factor RelA | 1 | 2012 | 275 | 0.100 |
Why?
|
| Oligopeptides | 2 | 2015 | 1189 | 0.100 |
Why?
|
| Genomics | 4 | 2013 | 5717 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 480 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2019 | 1253 | 0.100 |
Why?
|
| Mice, Inbred Strains | 3 | 2010 | 1828 | 0.100 |
Why?
|
| Protein Binding | 2 | 2018 | 9384 | 0.100 |
Why?
|
| Time Factors | 7 | 2019 | 40075 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2016 | 720 | 0.090 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 386 | 0.090 |
Why?
|
| Reproducibility of Results | 5 | 2014 | 19905 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2017 | 1157 | 0.090 |
Why?
|
| Aldehydes | 1 | 2011 | 167 | 0.090 |
Why?
|
| Toll-Like Receptors | 2 | 2005 | 593 | 0.090 |
Why?
|
| Bacterial Toxins | 2 | 1999 | 931 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 634 | 0.090 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2012 | 118 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2013 | 767 | 0.090 |
Why?
|
| Fimbriae Proteins | 2 | 2002 | 134 | 0.090 |
Why?
|
| Diptera | 1 | 2010 | 53 | 0.090 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 2009 | 27 | 0.090 |
Why?
|
| Chlorobenzoates | 1 | 2009 | 6 | 0.090 |
Why?
|
| Proteobacteria | 1 | 2009 | 45 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 4 | 2008 | 6171 | 0.090 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2012 | 250 | 0.090 |
Why?
|
| Open Reading Frames | 2 | 2004 | 811 | 0.090 |
Why?
|
| Fatty Acids | 3 | 2013 | 1809 | 0.090 |
Why?
|
| Length of Stay | 1 | 2023 | 6311 | 0.090 |
Why?
|
| Aging | 2 | 2020 | 8664 | 0.080 |
Why?
|
| Binding Sites | 1 | 2018 | 6111 | 0.080 |
Why?
|
| ras Proteins | 2 | 2012 | 1060 | 0.080 |
Why?
|
| Gene Expression Regulation | 6 | 2016 | 12073 | 0.080 |
Why?
|
| Vibrio cholerae | 2 | 2009 | 807 | 0.080 |
Why?
|
| Magnetite Nanoparticles | 1 | 2010 | 321 | 0.080 |
Why?
|
| Dextrans | 1 | 2010 | 595 | 0.080 |
Why?
|
| Troponin C | 1 | 2007 | 25 | 0.080 |
Why?
|
| Enterocytes | 1 | 2009 | 225 | 0.080 |
Why?
|
| Oxyquinoline | 1 | 2007 | 15 | 0.080 |
Why?
|
| Virus Cultivation | 1 | 2007 | 92 | 0.080 |
Why?
|
| Staphylococcal Infections | 1 | 2017 | 1400 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2018 | 2921 | 0.080 |
Why?
|
| Immune Tolerance | 1 | 2016 | 2259 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2018 | 5451 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2018 | 1887 | 0.070 |
Why?
|
| Burkholderia | 1 | 2007 | 38 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2016 | 3084 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 4424 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2010 | 479 | 0.070 |
Why?
|
| Blotting, Southern | 1 | 2008 | 803 | 0.070 |
Why?
|
| Molecular Sequence Data | 7 | 2006 | 18111 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2020 | 53290 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2021 | 19233 | 0.070 |
Why?
|
| Intestinal Neoplasms | 1 | 2009 | 319 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2019 | 9849 | 0.070 |
Why?
|
| Genes, ras | 1 | 2009 | 690 | 0.070 |
Why?
|
| Dynorphins | 1 | 2007 | 84 | 0.070 |
Why?
|
| Caenorhabditis elegans | 3 | 2001 | 1418 | 0.070 |
Why?
|
| Moths | 3 | 2001 | 87 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2019 | 2789 | 0.070 |
Why?
|
| Plasmids | 2 | 2008 | 2308 | 0.070 |
Why?
|
| Electroporation | 1 | 2008 | 251 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2009 | 1185 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2006 | 300 | 0.070 |
Why?
|
| Thiazoles | 1 | 2013 | 1483 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2019 | 3680 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2009 | 1202 | 0.070 |
Why?
|
| Age Factors | 3 | 2019 | 18373 | 0.070 |
Why?
|
| Random Allocation | 2 | 2010 | 2428 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2010 | 1547 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2013 | 5181 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2015 | 21748 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 2725 | 0.070 |
Why?
|
| Cell Count | 1 | 2009 | 1856 | 0.070 |
Why?
|
| Metabolomics | 1 | 2013 | 1485 | 0.060 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3047 | 0.060 |
Why?
|
| Suppression, Genetic | 1 | 2005 | 196 | 0.060 |
Why?
|
| Biological Evolution | 2 | 2001 | 1077 | 0.060 |
Why?
|
| Histones | 1 | 2015 | 2598 | 0.060 |
Why?
|
| Drosophila | 1 | 2012 | 1491 | 0.060 |
Why?
|
| Myeloid Cells | 1 | 2009 | 810 | 0.060 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 2015 | 165 | 0.060 |
Why?
|
| Lipids | 3 | 2014 | 3307 | 0.060 |
Why?
|
| Acute Disease | 2 | 2013 | 7147 | 0.060 |
Why?
|
| Female | 12 | 2020 | 380193 | 0.060 |
Why?
|
| Genome, Bacterial | 2 | 2006 | 760 | 0.060 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2006 | 506 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 4 | 2009 | 4805 | 0.060 |
Why?
|
| Overweight | 1 | 2015 | 2371 | 0.060 |
Why?
|
| Plant Roots | 1 | 2003 | 109 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2015 | 23336 | 0.060 |
Why?
|
| Cryptococcus neoformans | 1 | 2004 | 119 | 0.060 |
Why?
|
| Pneumonia | 1 | 2015 | 2133 | 0.060 |
Why?
|
| Recurrence | 1 | 2015 | 8340 | 0.060 |
Why?
|
| RNA, Bacterial | 1 | 2005 | 390 | 0.060 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 277 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2023 | 77460 | 0.050 |
Why?
|
| Risk Factors | 2 | 2020 | 72296 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2006 | 1723 | 0.050 |
Why?
|
| Adult | 7 | 2020 | 214052 | 0.050 |
Why?
|
| Smoking | 1 | 2019 | 8987 | 0.050 |
Why?
|
| Glycerophospholipids | 1 | 2022 | 32 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2018 | 35425 | 0.050 |
Why?
|
| Animal Testing Alternatives | 1 | 2002 | 14 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15535 | 0.050 |
Why?
|
| Phylogeny | 1 | 2009 | 2804 | 0.050 |
Why?
|
| Cell Division | 1 | 2009 | 4569 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14561 | 0.050 |
Why?
|
| United States | 2 | 2020 | 69872 | 0.050 |
Why?
|
| Regeneration | 1 | 2011 | 1485 | 0.050 |
Why?
|
| Phospholipases A | 1 | 2022 | 216 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 8949 | 0.050 |
Why?
|
| Hexuronic Acids | 2 | 2017 | 144 | 0.050 |
Why?
|
| Glucuronic Acid | 2 | 2017 | 148 | 0.050 |
Why?
|
| Erwinia | 1 | 2001 | 23 | 0.050 |
Why?
|
| Burkholderia cepacia | 1 | 2001 | 22 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 5749 | 0.050 |
Why?
|
| Operon | 1 | 2001 | 363 | 0.050 |
Why?
|
| Sigma Factor | 1 | 2001 | 175 | 0.050 |
Why?
|
| Codon, Nonsense | 1 | 2001 | 281 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4751 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2007 | 2204 | 0.040 |
Why?
|
| Cell Movement | 1 | 2012 | 5218 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2005 | 1677 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2004 | 1899 | 0.040 |
Why?
|
| Insulin | 2 | 2014 | 6582 | 0.040 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2001 | 371 | 0.040 |
Why?
|
| Chromatography, Liquid | 2 | 2017 | 976 | 0.040 |
Why?
|
| Child | 4 | 2023 | 77709 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15078 | 0.040 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2002 | 560 | 0.040 |
Why?
|
| Middle Aged | 5 | 2020 | 213390 | 0.040 |
Why?
|
| Amino Acids | 3 | 2010 | 1737 | 0.040 |
Why?
|
| Biological Therapy | 1 | 2019 | 138 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2006 | 2751 | 0.040 |
Why?
|
| Cell Line | 1 | 2012 | 16000 | 0.040 |
Why?
|
| Permeability | 1 | 2020 | 738 | 0.040 |
Why?
|
| Feedback | 1 | 2001 | 795 | 0.040 |
Why?
|
| Brain Neoplasms | 2 | 2011 | 8861 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 839 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2019 | 230 | 0.040 |
Why?
|
| Young Adult | 3 | 2019 | 56429 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 14723 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10183 | 0.040 |
Why?
|
| Cell Survival | 1 | 2007 | 5882 | 0.040 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2010 | 563 | 0.040 |
Why?
|
| Computational Biology | 1 | 2009 | 3519 | 0.040 |
Why?
|
| Escherichia coli | 3 | 2001 | 4217 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2009 | 3390 | 0.040 |
Why?
|
| Stem Cells | 1 | 2009 | 3567 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2002 | 861 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2011 | 9145 | 0.030 |
Why?
|
| Point Mutation | 1 | 2001 | 1624 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2001 | 1073 | 0.030 |
Why?
|
| Metabolome | 2 | 2014 | 895 | 0.030 |
Why?
|
| Phospholipases | 1 | 1995 | 72 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2009 | 11486 | 0.030 |
Why?
|
| Genetic Complementation Test | 2 | 1999 | 562 | 0.030 |
Why?
|
| Exotoxins | 1 | 1995 | 119 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 297 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 2 | 2008 | 481 | 0.030 |
Why?
|
| Gene Library | 2 | 2002 | 1074 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2005 | 2556 | 0.030 |
Why?
|
| Oxidation-Reduction | 2 | 2013 | 2184 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10483 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2005 | 2897 | 0.030 |
Why?
|
| Aconitate Hydratase | 1 | 2013 | 15 | 0.030 |
Why?
|
| Neoplasms | 2 | 2013 | 21696 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2013 | 137 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2007 | 11031 | 0.030 |
Why?
|
| Gastric Lavage | 1 | 2012 | 18 | 0.030 |
Why?
|
| Obesity | 1 | 2015 | 12746 | 0.030 |
Why?
|
| Plants, Toxic | 1 | 1992 | 76 | 0.030 |
Why?
|
| Succinates | 1 | 1992 | 82 | 0.030 |
Why?
|
| Survival Rate | 1 | 2006 | 12788 | 0.030 |
Why?
|
| DNA Transposable Elements | 2 | 1999 | 748 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2015 | 40559 | 0.030 |
Why?
|
| Citrates | 1 | 1992 | 131 | 0.030 |
Why?
|
| Mice, Inbred AKR | 2 | 2001 | 107 | 0.030 |
Why?
|
| RNA, Messenger | 4 | 2009 | 13035 | 0.030 |
Why?
|
| Citric Acid | 1 | 1992 | 126 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2019 | 974 | 0.030 |
Why?
|
| Fabaceae | 1 | 1992 | 103 | 0.030 |
Why?
|
| Succinic Acid | 1 | 1992 | 82 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 1992 | 475 | 0.030 |
Why?
|
| Genome, Human | 1 | 2005 | 4420 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 1992 | 167 | 0.030 |
Why?
|
| Endotoxemia | 1 | 2013 | 207 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6366 | 0.020 |
Why?
|
| Cosmids | 1 | 1991 | 107 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 712 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 1 | 1992 | 346 | 0.020 |
Why?
|
| Cloning, Molecular | 3 | 2002 | 4320 | 0.020 |
Why?
|
| Receptors, Glucagon | 1 | 2010 | 92 | 0.020 |
Why?
|
| Genes, Mitochondrial | 1 | 2010 | 61 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 878 | 0.020 |
Why?
|
| Carbohydrates | 1 | 1992 | 394 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 1992 | 295 | 0.020 |
Why?
|
| Phenotype | 3 | 2002 | 16367 | 0.020 |
Why?
|
| Chromosomes, Bacterial | 1 | 1991 | 282 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 1420 | 0.020 |
Why?
|
| PPAR delta | 1 | 2009 | 43 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2017 | 961 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 2010 | 291 | 0.020 |
Why?
|
| Cluster Analysis | 2 | 2007 | 2715 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2012 | 599 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 1997 | 1939 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2460 | 0.020 |
Why?
|
| Phosphorus Isotopes | 1 | 2008 | 126 | 0.020 |
Why?
|
| Multipotent Stem Cells | 1 | 2009 | 186 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 2017 | 1178 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2009 | 964 | 0.020 |
Why?
|
| PPAR alpha | 1 | 2009 | 197 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2012 | 749 | 0.020 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2008 | 250 | 0.020 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2007 | 24 | 0.020 |
Why?
|
| Muscular Atrophy | 1 | 2010 | 347 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8642 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 1793 | 0.020 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2010 | 547 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 2086 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 2007 | 624 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 402 | 0.020 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2006 | 129 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 565 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2002 | 2839 | 0.020 |
Why?
|
| Infant | 3 | 2015 | 35134 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 822 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2022 | 7882 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2015 | 41005 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3589 | 0.020 |
Why?
|
| Ocimum basilicum | 1 | 2003 | 1 | 0.020 |
Why?
|
| Depsides | 1 | 2003 | 4 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 644 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 2005 | 183 | 0.010 |
Why?
|
| Neutropenia | 1 | 2009 | 895 | 0.010 |
Why?
|
| Glycolysis | 1 | 2008 | 829 | 0.010 |
Why?
|
| Carbohydrate Metabolism | 1 | 2005 | 265 | 0.010 |
Why?
|
| Cinnamates | 1 | 2003 | 60 | 0.010 |
Why?
|
| Colon | 1 | 2012 | 1772 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1992 | 3773 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2006 | 772 | 0.010 |
Why?
|
| Digestive System | 1 | 2004 | 253 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2010 | 1783 | 0.010 |
Why?
|
| Phantoms, Imaging | 1 | 2010 | 2480 | 0.010 |
Why?
|
| Nitrogen Compounds | 1 | 2001 | 6 | 0.010 |
Why?
|
| RNA Polymerase Sigma 54 | 1 | 2001 | 11 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 4740 | 0.010 |
Why?
|
| Carbohydrate Dehydrogenases | 1 | 2001 | 10 | 0.010 |
Why?
|
| Swine | 1 | 2012 | 5918 | 0.010 |
Why?
|
| Principal Component Analysis | 1 | 2005 | 940 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 2216 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 491 | 0.010 |
Why?
|
| Phosphates | 1 | 2005 | 785 | 0.010 |
Why?
|
| Adolescent | 3 | 2015 | 85779 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 1903 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2005 | 694 | 0.010 |
Why?
|
| Bacterial Adhesion | 1 | 2001 | 316 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2716 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2012 | 3690 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2916 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 2009 | 2073 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2015 | 7730 | 0.010 |
Why?
|
| Prognosis | 2 | 2011 | 29060 | 0.010 |
Why?
|
| Azotobacter vinelandii | 1 | 1999 | 26 | 0.010 |
Why?
|
| Phenazines | 1 | 1999 | 58 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2000 | 963 | 0.010 |
Why?
|
| Fimbriae, Bacterial | 1 | 1998 | 138 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2008 | 6459 | 0.010 |
Why?
|
| Wakefulness | 1 | 2005 | 1245 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 10252 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1999 | 683 | 0.010 |
Why?
|
| Cell Wall | 1 | 2000 | 422 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2011 | 2213 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 2917 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2007 | 5077 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2011 | 6194 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2000 | 2646 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 9735 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1999 | 431 | 0.010 |
Why?
|
| Leukocytes | 1 | 2005 | 2045 | 0.010 |
Why?
|
| Neisseria gonorrhoeae | 1 | 1999 | 238 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1999 | 655 | 0.010 |
Why?
|
| Cholera Toxin | 1 | 1998 | 556 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2009 | 5023 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 6386 | 0.010 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1998 | 404 | 0.010 |
Why?
|
| Software | 1 | 2010 | 4441 | 0.010 |
Why?
|
| Biopsy | 1 | 2007 | 6755 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2015 | 25628 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10943 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 2751 | 0.010 |
Why?
|
| Patient Selection | 1 | 2005 | 4216 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 6773 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 8432 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 12952 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 13814 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 25039 | 0.010 |
Why?
|
| Skin | 1 | 2001 | 4372 | 0.000 |
Why?
|
| Aged | 1 | 2015 | 163288 | 0.000 |
Why?
|